CORT Latest Headlines

Corcept Therapeutics Q4 2025 Earnings Preview

at seekingalpha.com (Mon, 23-Feb 5:35 PM)

Quant snapshot: Amerigo, Allianz lead strong buys as Ashford Hospitality, Hudson Pacific lag

at seekingalpha.com (Sun, 22-Feb 9:15 AM)

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), Pulse Biosciences (PLSE) and Corcept Therapeutics (CORT)

at www.tipranks.com (Fri, 20-Feb 8:20 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Talkspace (TALK), ICU Medical (ICUI) and Corcept Therapeutics (CORT)

at www.tipranks.com (Fri, 20-Feb 7:20 AM)

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Praxis Precision Medicines (PRAX) and Dogwood Therapeutics (DWTX)

at www.tipranks.com (Fri, 20-Feb 6:20 AM)

Corcept Faces Appellate Setback in Korlym Patent Dispute

at www.tipranks.com (Thu, 19-Feb 5:28 PM)

Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!

at www.tipranks.com (Thu, 19-Feb 11:56 AM)

Corcept Therapeutics Stock Crashes 21% after Patent Defeat to Teva

at www.tipranks.com (Thu, 19-Feb 11:36 AM)

Corcept Therapeutics Down 21%: Why Is CORT Stock Crashing Today?

at www.tipranks.com (Thu, 19-Feb 11:36 AM)

Corcept falls as appeals court sides with Teva in Korlym patent dispute

at seekingalpha.com (Thu, 19-Feb 11:10 AM)

Corcept Therapeutics Hit By Shareholder Investigation As FDA Rejection Erases $3.6 Billion in Value

Market Chameleon (Thu, 22-Jan 11:19 AM)

Corcept’s Phase 3 ROSELLA Trial Shows Significant Survival Benefit for Relacorilant in Platinum-Resistant Ovarian Cancer

Market Chameleon (Thu, 22-Jan 8:45 AM)

FDA Requests More Data for Corcept’s Relacorilant, Prompting Rethink of Approval Path

Market Chameleon (Fri, 2-Jan 10:30 AM)

FDA Requests More Data on Corcept’s Relacorilant for Hypercortisolism—What’s Next for This Promising Cortisol Modulator?

Market Chameleon (Wed, 31-Dec 8:19 AM)